To further determine whether BYHWD exerts its anti‐AD effects by modulating the gut microbiota and subsequently suppressing the C/EBPβ/AEP pathway, we administered FMT‐BYHWD treatment to 3×Tg mice (Figure 5A). Here, LGMN is linked to Alzheimer disease.